Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page updated to Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform update and does not change the study content.
    Difference
    0.1%
    Check dated 2026-08-11T13:45:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces v3.6.3 on the page, reflecting a minor metadata update. This does not change the study content or visible details.
    Difference
    0.1%
    Check dated 2026-07-28T03:05:59.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision stamp updated from v3.6.2 to v3.6.3. This reflects a page template revision and does not alter the study details displayed.
    Difference
    0.1%
    Check dated 2026-07-06T18:12:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a new version of the ClinicalTrials.gov page rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-06-29T13:49:40.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended ('No longer looking for participants'), and there are minor navigational/formatting updates (the Intervention/Treatment heading formatting, newly added help sections such as 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and an updated revision tag from v3.5.5 to v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T08:15:02.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, reflecting a minor maintenance update to the site's versioning for this page. No study content or data is altered.
    Difference
    0.1%
    Check dated 2026-06-08T04:11:51.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.